Back to Authors

McManus, Michael J.

Mayo Clinic

Mayo Clinic

Citations 3

Ras-independent oncogenic transformation by an EGF-receptor mutant
Boerner, Julie L. , McManus, Michael J., Maihle, Nita J. , Martin, G. Steven

Journal of Cell Science | April 25, 2021 | Volume: 113 | Issue: 6 | Pages: 935-942

10.1242/jcs.113.6.935 Get It

ABSTRACT Mutations in the ligand-binding domain of the epidermal growth factor receptor have been identified in several types of human cancers, including malignant gliomas. These mutations render signaling by this receptor to be constitutively ligand-independent. In fibroblasts transformed with ligand-independent epidermal growth factor receptor mutants, there is a correlation between the formation of a unique phosphotyrosine protein complex and oncogenic transformation. This phosphoprotein complex includes Grb2, Shc, Sos, tyrosine-phosphorylated form of caldesmon, and two, as yet, unidentified proteins. The presence of Grb2, Shc, and Sos in this complex implicates Ras in ligand-independent signaling by these oncogenic epidermal growth factor receptor mutants. We, therefore, have used retroviral co-infections of cultured primary fibroblasts to determine if Ras activation is required for phosphoprotein complex formation, stress fiber loss, or transformation. As predicted, expression of a dominant-negative Ras mutant (N17Ras) completely abrogates ligand-stimulated soft agar colony growth of primary fibroblasts. In contrast, N17Ras expression has no effect on v-ErbB mediated stress fiber disassembly, soft agar colony growth, or phosphoprotein complex assembly. In addition, our data suggest that ligand-dependent Ras activation may be suppressed by oncogenic v-ErbB expression. Together these observations suggest that oncogenic signaling by v-ErbB does not require Ras activation, and implicate an alternative signal transduction pathway in ligand-independent epidermal growth factor receptor oncogenic signaling.
Bilateral Primary Neuroblastomas in the Inguinal Canal
Leo, Mark E., McManus, Michael J., Strawbridge, Lawrence R., Kramer, Stephen A.

Journal of Urology | June 30, 2017 | Volume: 148 | Issue: 1 | Pages: 135-137

10.1016/s0022-5347(17)36536-9 Get It

A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-ErbB signaling to actin stress fiber disassembly
McManus, Michael J., Lingle, Wilma L., Salisbury, Jeffrey L., Maihle, Nita J.

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 94 | Issue: 21 | Pages: 11351-11356

10.1073/pnas.94.21.11351 Get It

The avian erythroblastosis viral oncogene (v- erb B) encodes a receptor tyrosine kinase that possesses sarcomagenic and leukemogenic potential. We have expressed transforming and nontransforming mutants of v- erb B in fibroblasts to detect transformation-associated signal transduction events. Coimmunoprecipitation and affinity chromatography have been used to identify a transformation-associated, tyrosine phosphorylated, multiprotein complex. This complex consists of Src homologous collagen protein (Shc), growth factor receptor binding protein 2 (Grb2), son of sevenless (Sos), and a novel tyrosine phosphorylated form of the cytoskeletal regulatory protein caldesmon. Immunofluorescence localization studies further reveal that, in contrast to the distribution of caldesmon along actin stress fibers in normal fibroblasts, caldesmon colocalizes with Shc in plasma membrane blebs in transformed fibroblasts. This colocalization of caldesmon and Shc correlates with actin stress fiber disassembly and v- erb B-mediated transformation. The tyrosine phosphorylation of caldesmon, and its association with the Shc–Grb2–Sos signaling complex directly links tyrosine kinase oncogenic signaling events with cytoskeletal regulatory processes, and may define one mechanism regulating actin stress fiber disassembly in transformed cells.